What Are the Risks of Anticoagulation Therapy During Pregnancy?
Anticoagulation therapy presents risks to both the mother and the fetus. Warfarin, for instance, can cross the placental barrier and may cause congenital anomalies, fetal bleeding, or stillbirth. Low molecular weight heparin is generally considered safer during pregnancy but requires frequent monitoring. The balance between preventing maternal thromboembolism and minimizing fetal risk is delicate and requires individualized care.
